Skip to main content
. 2021 Jan 20;11:603947. doi: 10.3389/fneur.2020.603947

Figure 3.

Figure 3

Forest plot of PFS in glioblastoma between lomustine plus bevacizumab and control groups. (A) All of the studies were included. (B) The study of Wick was removed. PFS, progression-free survival; Lom, lomustine; Bev, bevacizumab.